Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pathophysiology > Neoplasia > Flashcards

Neoplasia Flashcards

0
Q

neoplasm

A

abnormal mass of tissue; growth of which exceeds and is uncoordinated w/ that of the normal tissues and persists after cessation of the stimulus which evoked the change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Neoplasia

A

New growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Neoplasms arise from…

A

cells that have proliferative capacity; **mature neurons and cardiac myocytes don’t give rise to turmors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Things that can cause neoplasia

A
  • mutations in genes that regulate growth
  • apoptosis
  • DNA repair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anaplastic / cellular atypia

A

lack of differentiated features (morphologically or functionally) in cancers

  • pleomorphism
  • enlarged hyperchromatic nuclei
  • atypical mitoses
  • bizarre cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What must cancers have?

A

Stem - like properties

  • arise from tissue stem cells
  • arise from more differentiated cells that transform and acquire the self renewal ability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

benign

A

microscopic and gross characteristics are considered to be innocent; WILL NOT METASTASIZE OR INVADE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

malignant

A

tumors collectively referred to as cancer; CAN INVADE, DESTROY, METASTASIZE TO DISTANT SITES AND CAUSE DEATH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do benign and malignant relate to?

A

the biological behavior rather than morphology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Primary descriptor of any tumor

A

cell of origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

secondary descriptor of any tumor

A

morphologic or functional characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Benign tumor suffix

A
  • oma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adenoma

A

benign, arises from a gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

epithelioma or papilloma

A

benign and arise form epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

medullary

A

soft and cellular w/ little stroma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

comedo

A

with a duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Malignant tumor suffix for EPITHELIAL cancers

A

carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Malignant tumor suffix for cancers of MESENCHYMAL origin

A

sarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

-emia

A

relationship to blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Teratoma

A

benign tumor arising form germ cells (hair/teeth)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hamartoma

A

localized, disordered differentiation during EMBRYOGENESIS that results in disorganized composition of the tissue elements of an organ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How may Hamartomas manifest?

A

either singly or in combination

1) abnormal quantity
2) abnormal structure
3) degree of maturation of the tissue components

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Choriostoma

A

Ectopic islands of normal tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Hepatoma

A

malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

melanoma

A

malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

seminoma

A

malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

lymphoma

A

malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Brenner tumor

A

malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Hodgkin disease

A

malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What 2 basic components do all tumors share? (both benign and malignant)

A

1) PARENCHYMA composed of transformed or neoplastic cells

2) STROMA - support tissue that is host derived and composed of connective tissue, blood vessels, and inflammatory cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the gold standard for diagnosing a cancer?

A

Routine microscopy (there are no reliable molecular indicators)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Ewing sarcoma

A

malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What criteria are used to assess the true biological nature of a tumor?

A

Histological correlation of histologic and cytologic patterns w/ clinical outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Fibrosarcoma and nodular fasciitis

A

Fibrosarcoma - malignant
Nodular fasciitis - benign; has a more alarming histologic appearance than many fibrosarcomas. Misdiagnosis can lead to unnecessary surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Benign tumors and histologic and cytologic characteristics

A

benign tumors tend to be histologically and cytologically similar to their tissues of origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Benign tumors and gross structure

A

May differ from tissue of origins; assume papillary and polypoid configurations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Malignant tumor morphology

A
  • differ from parent tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What distinguishes malignant from benign tumors?

A
  • differentiation and anaplasia
  • rate of growth
  • local invasion
  • metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Tumor markers

A
  • products of malignant neoplasms that can be detected in body fluids or in affected cells
  • can sometimes identify the cell or origin for metastases or a poorly differentiated primary tumor
  • preserve the characteristics of cells of origins or have specific protein products that define a certain neoplastic cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Types of markers include…

A
  • immunoglobulins
  • fetal proteins
  • enzymes
  • hormones
  • cytoskeleton or junctional proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Why do we need to identify the lineage of a neoplasm that is poorly differentiated or undifferentiated?

A

Treatment decisions can be based on tumor markers that are present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Tumor marker roles outside of determining lineage

A
  • can be used to screen for cancer
  • can be used to follow progression or resolution of cancer
  • can be therapeutic targets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

PSA

A

prostate-specific antigen

screen for prostate carcinoma
evaluate for recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

CEA

A

carcinoembyronic antigen

GI malignancies progression or recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

CA 125

A

ovarian carcinoma progression or recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

HER2

A

therapeutic target for breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Immunohistochemistry

A

using antibodies to visualize certain tissues bound antigens

  • conjugate an antigen to PEROXIDASE and there is a reaction that yields a color change
  • conjugate the antibody to something that is fluorescent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Tumor markers - immunohistochemical methods of diagnosis

CARCINOMAS

A
  • uniformally express cytokeratins (CKs)
  • prostatic carcinoma produces PSA
  • thyroid carcinomas can produce THYROGLOBULIN
  • breast cancers can have ESTROGEN AND PROGESTERONE RECEPTORS
  • LEWIS A ANTIGEN in PANCREATIC AND GASTROINTESTINAL CANCER
  • CA125 for ovarian cancer
49
Q

Chromogranins

A

Tumor markers - immunohistochemical methods in diagnosis
NEUROENDOCRINE TUMORS

contained in neurosecretory granules

50
Q

Synaptophysin

A

Tumor markers - immunohistochemical methods in diagnosis
NEUROENDOCRINE TUMORS

  • contained in adrenal and pancreatic islet cells
  • neuroblastoma, pheochromocytoma, medullary thyroid carcinoma
51
Q

Antibodies to peptide hormones produced

A

Tumor markers - immunohistochemical methods in diagnosis
NEUROENDOCRINE TUMORS

  • insulin, gastrin, ACTH, serotonin, somatostatin
52
Q

Tumor markers - immunohistochemical methods in diagnosis

MALIGNANT MELANOMA

A
  • may appear undifferentiated, unpigmented
  • express HMB-45 and S-100
  • NOT POSITIVE FOR CYTOKERATINS
53
Q

Tumor markers - immunohistochemical methods in diagnosis

MALIGNANT LYMPHOMAS

A
  • LCA (leukocyte common antigen)
  • CD markers for B or T cells
  • see lambda or kappa chains expressed on B cells (expression of only one type is consistent w/ a monoclonal B cell lymphoma)
54
Q

Tumor markers - immunohistochemical methods in diagnosis

VASCULAR TUMORS

A
  • antibodies against Factor VIII (8) - related antigen [CD31]
55
Q

Tumor markers - immunohistochemical methods in diagnosis

PROLIFERATING CELLS

A
  • PCNA (proliferating cell nuclear antigen) illustrates tumor growth rate
  • look for cycling cells where growth is not usually present [Ki-67]
56
Q

Tumor markers - immunohistochemical methods in diagnosis

SOFT TISSUE SARCOMAS

A
  • express VIMENTIN (anchoring organelles and having shape/form to cells
  • express DESMIN (in smooth or striated muscle fiber derived neoplasms)
  • MUSCLE SPECIFIC ACTING
57
Q

Invasion and metastases

A

local invasion and capacity to metastasize to distant sites are unique to malignant cells and responsible for many cancer deaths

metastases allow the cancer to persist EVEN AFTER SURGICAL RESECTION OF THE PRIMARY TUMOR

58
Q

Carcinoma in situ

A
  • dysplastic changes are marked and INVOLVE THE ENTIRE THICKNESS OF THE EPITHELIUM
  • CONTAINED BY THE BASEMENT MEMBRANE
  • PREINVASIVE NEOPLASM
  • CURABLE
59
Q

When is an in situ stage not defined?

A

in situations in which cancers arise from cells that are not confined by a basement membrane (such as connective tissue cells, lymphoid elements, and hepatocytes)

60
Q

Fistula

A

abnormal connection/passageway between 2 epithelium-lined organs or vessels

61
Q

invasion

A

growth within a tissue

  • enlarge and infiltrate throughout the tissue
  • can result in obstruction or functional insufficiency

extension beyond primary site
- tumor may secondarily impair the function of an adjacent organ

62
Q

Most common cause of cancer death

A

metastases

63
Q

What is metastases?

A
  • migration to a noncontiguous site
64
Q

How does metastases occur?

A

via hematogenous, lymphatic, or direct seeding routes

65
Q

Hematogenous metastases - common invasion sites

A

capillaries and venules (more thin walls)

thicker vessels are more resistant

66
Q

Where are metastases common??

A

Liver and lungs

67
Q

Place where mets can lodge and extend

A

lymph nodes

68
Q

Lymphatic capillaries _________ a basement membrane

A

Lack

69
Q

Initial sign of disease for lymphatic metastases

A

Lymph nodes enlarge

70
Q

Regional lymphatic metastases of the breast

A

Metastases primarily begin via lymphatics

*nodal involvement is on prognostic significance

71
Q

Regional lymphatic metastases of the breast - Cancers arising laterally

A

Axillary nodes

72
Q

Regional lymphatic metastases of the breast - cancers arising medial

A

internal mammary nodes

73
Q

Sentinel node

A

“first lymph node” to where the cancer will drain

- locate w/ a tracer such as die or scintigraphy (radioactive tag)

74
Q

skipped metastases

A
  • metastases are more distant

- prognosis is worse

75
Q

Direct seeding of metastases

A

Tumor cells are released into a BODY CAVITY

76
Q

Example of direct seeding of metasteses

A

ovary (mesentery or bowel can be involved)

77
Q

Tumor-Associated Host Cells

A
  • significant number of cells within tumor mass
  • fat cells, macs and leukocytes, fibroblasts, vascular endothelial cells, neural cells
  • nontumor cells can define the cancer behavior
  • CONCEPT OF PRODUCTS W/ MUTUALLY OPPOSITE EFFECTS
78
Q

Tumor-Associated Host Cells - Macrophages and Leukocytes

A

Macs will produce enzymes to digest basement membranes
- MMPs, cathepsins, u-PA

Macs promote inflammation and angiogenesis

79
Q

Tumor-Associated Host Cells - Adipocytes

A
  • Express a MMP that promotes cancer movement through the MATRIX
  • stimulate macs to secrete pro inflammatory cytokines through leptin production
80
Q

Adhesion molecules

A

Promote the entire process: necessary for invasion, metastases, and growth at the distant site

81
Q

Integrins

A

interaction BETWEEN CELLS and between CELLS and EXTRACELLULAR MATRIX

82
Q

Selectins

A

Binding between TUMOR CELLS and NONMALIGNANT TUMOR-ASSOCIATED CELLS

83
Q

Cadherins

A

Interaction AMONG TUMOR CELLS

84
Q

IgCAM superfamily (immunoglobulin cell adhesion molecule)

A

binding both AMONG TUMOR CELLS and BETWEEN TUMOR CELLS AND TUMOR-ASSOCIATED CELLS

85
Q

Upper limits of tumor diameter that can be supported w/o additional “supply line”

A

2mm diameter

86
Q

VEGF

A

Vascular Endothelial Growth Factor

  • Made by tumor cells
  • Most significant amount is made by connective tissue, platelets, and TAMS
  • acts on vascular endothelium to induce proliferation toward the source
87
Q

TAMs

A

Tumor Associated Macrophages

88
Q

VEGF, FGF, EGF, TGF-alpha

A

TAMs

  • growth factors for tumors
  • mitogens for endothelial cells
89
Q

Cytokines (TNF-alpha, IL-8)

A

TAMs
TNF can be pro and anti-tumor
IL-8 can stimulate angiogenesis

90
Q

TNF in low quantities

A

anti-tumor

91
Q

TNF in high quantities

A

favors angiogenesis and environment for tumors to grow

92
Q

In normal cells, GF interaction is…

A

paracrine in nature

93
Q

In neoplastic cells, GF interactions have…

A

an autocrine loop

- part of the immortality these cells have

94
Q

Examples of autocrine loops

A

Glioblastomas secrete PDGF and have receptors

Sarcomas secrete TGF-alpha and have receptors

95
Q

Oncogenes induce GF genes to…

A

Overproduce

this does not induce neoplastic transformation (does not make cancer)

96
Q

Quiescent intervals

A

tumor dormancy - present in cancer growth

97
Q

Tumor dormancy

A

presence of cancers, either primary or metastatic, that do not enlarge to the point of being clinically detectable

Tumor cells in G0 phase of the cell cycle

98
Q

Causes of tumor dormancy

A

growth arrest secondary to signaling

proliferation = death

99
Q

Monoclonal

A

1 cell transforms; all of its progeny make up the tumor

100
Q

Polyclonal

A

several cells transform, giving way to identical clones that make up this tumor; a little bit harder to treat depending on how each reacts

101
Q

Most cells are of what origin?

A

Monoclonal origin

102
Q

Spike on serum electrophoresis

A

indicates monoclonal transformation in the gamma regions (right)

103
Q

Tumor heterogeneity

A

the genotypic and phenotypic variation that occurs

104
Q

Clonal evolution

A

progressive accumulation of new mutations as they proliferate

Darwinian-style selection, “survival of the fittest” of tumors governs which subclones will succeed, die, metastasize, or remain localized

105
Q

3 different mechanisms responsible for mutations

A

1) chromosomal instability
2) microsatellite instability
3) aberrant DNA methylation

106
Q

Genomic instability as a contributor to cancer development - Chromosomal instability

A

additions and deletions of various sizes

results in

  • aneuploidy (imbalance in chromosomal numbers)
  • gene amplification (increase in gene copy number)
  • loss of heterozygosity (loss of allele out of a pair)
107
Q

Oncogenes

A

mutated genes that promote autonomous cell growth in cancer cells

108
Q

Proto oncogenes

A

“unmutated” cellular counterparts

- normal cell that can become an oncogene due to mutations or increased expression

109
Q

Oncoproteins

A

Gene products

  • lack regulatory components
  • do not depend on signals or GFs for production
110
Q

Where were oncogenes originally found?

A

in the oncogenically activated state in retroviruses and transformed cells

  • so oncogenes are in the normal non-oncogenically activated state in non-transformed cells
111
Q

Oncogene activation by mutation

A
  • includes point mutations, deletions, and translocations
  • Point mutations: result in alterations usually involving critical protein regulatory regions
  • leads to uncontrolled continuous activity of the mutated protein
  • activation is associated w/ somatic alterations due to unregulated growth
112
Q

c-ras

A

first human oncogene identified

113
Q

Oncogene activation by gene amplification

A
  • redundant replication of genomic DNA

- karyotypic abnormalities: double-minute chromosomes (DMs) and homogenous staining regions (HSRs)

114
Q

Double minutes (DMs)

A

“mini-chromosome structures” w/o centromeres

115
Q

Homogenous staining regions (HSRs)

A

segments of chromosomes lacking normal alternating light and dark staining bands (more genes, segments appear longer)

116
Q

Oncogene activation by chromosomal translocation

A
  • found in leukemias and lymphomas
  • keys are the proto-oncogene and the breakpoint cluster region
  • hybrid oncogene results in aberrant protein w/ high tyrosine kinase activity (mitogenic and antiapoptotic signals)
117
Q

Example of oncogene activation by chromosomal translocation

A

Philadelphia chromosome (bcr/abl fusion gene)

  • translocation in CML fuses c-abl gene, normally located at 9q34 w/ the bcr gene at 22q11
118
Q

Another example of oncogene activation chromosomal translocation

A

Burkitt lymphoma

c-myc gene, located at chromosome band 8q24 under control of regulatory elements from the immunoglobulin heavy chain locus located at 14q32

119
Q

Gain-of-function mutations

A

mutations giving increased activity

Pathophysiology (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions